U.S. Markets closed

UPDATE: GlycoMimetics shares soar 30% after positive trial of leukemia treatment

GlycoMimetics Inc. shares surged 30% in premarket trade Tuesday, after the company reported improvements in median overall survival rates in an early-stage trial of a treatment for acute myeloid leukemia ...